Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3520LO3W
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W 2.3 %
2W 0.3 %
1M -0.1 %
3M 3.8 %
6M 3.5 %
9M 11.0 %
1Y 10.1 %
Alpha
-3.2%
Beta
0.57
sharpe-R
0.55
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:44
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -9.69%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 20.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
2
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
PODD Insulet Corporation Equity Buy 5.65% 15.22%
ESPR Esperion Therapeutics, Inc. Equity Buy 4.77% -2.73%
NVCR NovoCure Limited Equity Buy 4.73% -0.17%
MYGN Myriad Genetics, Inc. Equity Buy 4.97% 6.04%
The percentage of cash held in the portfolio is: 79.87%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 5.63% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 4.73% -3.83%
NVCR NovoCure Limited Buy 4.72% -0.5%
MYGN Myriad Genetics, Inc. Buy 4.86% 3.45%
The percentage of cash held in the portfolio is: 80.06%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -2.28%
AADI Sell All 7.43%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 5.04% 1.14%
PODD Insulet Corporation Buy 5.62% 12.73%
MGNX MacroGenics, Inc. Buy 5.13% 2.85%
ESPR Esperion Therapeutics, Inc. Buy 4.77% -4.37%
TVTX Travere Therapeutics, Inc. Buy 6.44% 31.25%
NVCR NovoCure Limited Buy 4.62% -3.99%
MYGN Myriad Genetics, Inc. Buy 4.67% -2.15%
The percentage of cash held in the portfolio is: 63.7%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 8.41%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 5.16% 3.11%
AADI Aadi Bioscience, Inc. Buy 5.26% 5.14%
PODD Insulet Corporation Buy 5.58% 11.4%
MGNX MacroGenics, Inc. Buy 5.16% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 4.76% -4.92%
TVTX Travere Therapeutics, Inc. Buy 6.28% 27.5%
NVCR NovoCure Limited Buy 4.61% -4.54%
MYGN Myriad Genetics, Inc. Buy 4.67% -2.56%
The percentage of cash held in the portfolio is: 58.51%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -3.75%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.92% -1.69%
AGEN Agenus Inc. Buy 5% -0.18%
AADI Aadi Bioscience, Inc. Buy 5.09% 1.71%
PODD Insulet Corporation Buy 5.55% 10.8%
MGNX MacroGenics, Inc. Buy 5.08% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 4.73% -5.46%
TVTX Travere Therapeutics, Inc. Buy 6.59% 33.75%
NVCR NovoCure Limited Buy 4.53% -6.37%
MYGN Myriad Genetics, Inc. Buy 4.8% 0.26%
The percentage of cash held in the portfolio is: 53.71%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.03% 0.21%
CARA Cara Therapeutics, Inc. Buy 4.53% -9.62%
AGEN Agenus Inc. Buy 4.7% -6.22%
AADI Aadi Bioscience, Inc. Buy 5.19% 3.43%
PODD Insulet Corporation Buy 5.38% 7.2%
MGNX MacroGenics, Inc. Buy 4.93% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 4.66% -7.1%
TVTX Travere Therapeutics, Inc. Buy 6.61% 33.96%
NVCR NovoCure Limited Buy 4.46% -7.98%
MYGN Myriad Genetics, Inc. Buy 4.83% 0.63%
The percentage of cash held in the portfolio is: 49.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.22% 3%
CARA Cara Therapeutics, Inc. Buy 4.76% -6.12%
AGEN Agenus Inc. Buy 4.59% -9.51%
AADI Aadi Bioscience, Inc. Buy 5.3% 4.57%
PODD Insulet Corporation Buy 5.33% 5.05%
MGNX MacroGenics, Inc. Buy 4.7% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 4.57% -9.84%
TVTX Travere Therapeutics, Inc. Buy 5.7% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 4.75% -3.01%
NVCR NovoCure Limited Buy 4.58% -6.48%
MYGN Myriad Genetics, Inc. Buy 4.85% 0%
The percentage of cash held in the portfolio is: 45.65%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.98% -1.42%
ORGO Organogenesis Holdings Inc. Buy 4.71% -6.71%
CARA Cara Therapeutics, Inc. Buy 4.73% -6.41%
AGEN Agenus Inc. Buy 4.62% -8.59%
AADI Aadi Bioscience, Inc. Buy 5.2% 2.86%
PODD Insulet Corporation Buy 5.34% 5.72%
MGNX MacroGenics, Inc. Buy 4.87% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 4.75% -6.01%
TVTX Travere Therapeutics, Inc. Buy 5.14% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 4.88% 0%
NVCR NovoCure Limited Buy 4.88% 0%
The percentage of cash held in the portfolio is: 45.91%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.79% -5.21%
ORGO Organogenesis Holdings Inc. Buy 4.82% -4.59%
CARA Cara Therapeutics, Inc. Buy 4.75% -6.12%
AGEN Agenus Inc. Buy 4.48% -11.33%
AADI Aadi Bioscience, Inc. Buy 5.2% 2.86%
PODD Insulet Corporation Buy 5.26% 3.96%
MGNX MacroGenics, Inc. Buy 4.78% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 5.03% -0.55%
TVTX Travere Therapeutics, Inc. Buy 5.2% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 4.88% 0%
The percentage of cash held in the portfolio is: 50.81%
New Assets Added
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.92% -2.65%
ORGO Organogenesis Holdings Inc. Buy 4.87% -3.53%
CARA Cara Therapeutics, Inc. Buy 4.88% -3.5%
AGEN Agenus Inc. Buy 4.57% -9.51%
CERS Cerus Corporation Buy 4.65% -7.98%
AADI Aadi Bioscience, Inc. Buy 5.02% -0.57%
PODD Insulet Corporation Buy 5.11% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 4.53% -10.38%
MGNX MacroGenics, Inc. Buy 4.72% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 5.05% 0%
TVTX Travere Therapeutics, Inc. Buy 4.97% 0%
The percentage of cash held in the portfolio is: 46.71%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.77% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 4.8% -2.4%
ORGO Organogenesis Holdings Inc. Buy 5.01% 1.77%
CARA Cara Therapeutics, Inc. Buy 5.16% 4.96%
AGEN Agenus Inc. Buy 4.63% -5.85%
CERS Cerus Corporation Buy 4.67% -5.04%
AADI Aadi Bioscience, Inc. Buy 5.09% 3.43%
NEOG Neogen Corporation Buy 4.94% 0.35%
PODD Insulet Corporation Buy 4.88% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 4.86% -1.15%
MGNX MacroGenics, Inc. Buy 4.92% 0%
ESPR Esperion Therapeutics, Inc. Buy 4.92% 0%
The percentage of cash held in the portfolio is: 41.35%
New Assets Added
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.78% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 4.74% -4.2%
ORGO Organogenesis Holdings Inc. Buy 5.12% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.13% 3.79%
AGEN Agenus Inc. Buy 4.62% -6.58%
CERS Cerus Corporation Buy 4.65% -5.88%
AADI Aadi Bioscience, Inc. Buy 4.75% -4%
NEOG Neogen Corporation Buy 4.84% -2.15%
PODD Insulet Corporation Buy 4.95% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 4.95% 0%
The percentage of cash held in the portfolio is: 51.48%
New Assets Added
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.78% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 4.86% -0.64%
ORGO Organogenesis Holdings Inc. Buy 5.09% 3.89%
CARA Cara Therapeutics, Inc. Buy 5.12% 4.66%
AGEN Agenus Inc. Buy 5.04% 2.93%
CERS Cerus Corporation Buy 4.77% -2.52%
AADI Aadi Bioscience, Inc. Buy 4.7% -4%
NEOG Neogen Corporation Buy 4.9% 0%
The percentage of cash held in the portfolio is: 60.74%
New Assets Added
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.8% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 4.85% -0.05%
ORGO Organogenesis Holdings Inc. Buy 5.19% 7.07%
CARA Cara Therapeutics, Inc. Buy 5.23% 7.87%
AGEN Agenus Inc. Buy 5.2% 7.31%
CERS Cerus Corporation Buy 4.85% 0%
AADI Aadi Bioscience, Inc. Buy 4.85% 0%
The percentage of cash held in the portfolio is: 65.02%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.68% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 4.83% -1.79%
ORGO Organogenesis Holdings Inc. Buy 4.78% -2.83%
CARA Cara Therapeutics, Inc. Buy 4.92% 0%
AGEN Agenus Inc. Buy 4.92% 0%
The percentage of cash held in the portfolio is: 75.86%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.9% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 4.9% 0%
ORGO Organogenesis Holdings Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 85.3%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All -1.57%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 4.29% -7.66%
The percentage of cash held in the portfolio is: 95.71%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
RCM Sell All 7.14%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 4.82% 7.06%
CYH Community Health Systems, Inc. Buy 4.39% -5.3%
RMD ResMed Inc. Buy 4.43% 3.67%
The percentage of cash held in the portfolio is: 86.36%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All -5.42%
FATE Sell All 7.71%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 5.69% -1.06%
FATE Fate Therapeutics, Inc. Buy 6.84% 19.02%
RCM R1 RCM Inc. Buy 4.79% 7.83%
CYH Community Health Systems, Inc. Buy 4.49% -1.96%
RMD ResMed Inc. Buy 4.54% 7.5%
The percentage of cash held in the portfolio is: 73.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
MASI Sell All -5.02%
HQY Sell All -11.82%
SAVA Sell All 95.11%
SAGE Sell All -12.65%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
MASI Masimo Corporation Buy 4.22% -4.14%
BKD Brookdale Senior Living Inc. Buy 5.85% 1.06%
FATE Fate Therapeutics, Inc. Buy 7.27% 25.45%
RCM R1 RCM Inc. Buy 4.86% 8.44%
CYH Community Health Systems, Inc. Buy 4.54% -1.57%
HQY HealthEquity, Inc. Buy 4.44% -3.84%
SAVA Cassava Sciences, Inc. Buy 7.27% 57.44%
SAGE Sage Therapeutics, Inc. Buy 4.1% -11.19%
HCSG Healthcare Services Group, Inc. Buy 4.3% -3.72%
RMD ResMed Inc. Buy 4.39% 3.13%
The percentage of cash held in the portfolio is: 48.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
ANGO Sell All 27.08%
SGRY Sell All 18.28%
AVNS Sell All 12.13%
CUTR Sell All -12.16%
RGNX Sell All 4.72%
SUPN Sell All 3.79%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.59% 27.9%
SGRY Surgery Partners, Inc. Buy 5.19% 18.83%
AVNS Avanos Medical, Inc. Buy 4.93% 12.94%
CUTR Cutera, Inc. Buy 4.13% -5.41%
RGNX REGENXBIO Inc. Buy 4.9% 12.12%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.57% 4.67%
MASI Masimo Corporation Buy 4.15% -4.45%
BKD Brookdale Senior Living Inc. Buy 5.83% 2.25%
FATE Fate Therapeutics, Inc. Buy 7.82% 37.02%
RCM R1 RCM Inc. Buy 4.36% -1.15%
CYH Community Health Systems, Inc. Buy 4.7% 3.34%
HQY HealthEquity, Inc. Buy 4.41% -3.09%
SAVA Cassava Sciences, Inc. Buy 6.77% 48.93%
SAGE Sage Therapeutics, Inc. Buy 4.53% -0.36%
HCSG Healthcare Services Group, Inc. Buy 4.35% -1.12%
RMD ResMed Inc. Buy 4.3% 2.5%
The percentage of cash held in the portfolio is: 19.47%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All 1.14%
OPK Sell All 7.58%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.38% -1.7%
OPK OPKO Health, Inc. Buy 4.83% 8.33%
ANGO AngioDynamics, Inc. Buy 5.68% 27.73%
SGRY Surgery Partners, Inc. Buy 5.44% 22.27%
AVNS Avanos Medical, Inc. Buy 4.82% 8.4%
CUTR Cutera, Inc. Buy 4.33% -2.7%
RGNX REGENXBIO Inc. Buy 5% 12.43%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.73% 6.28%
MASI Masimo Corporation Buy 4.2% -4.93%
BKD Brookdale Senior Living Inc. Buy 6.01% 3.44%
FATE Fate Therapeutics, Inc. Buy 7.66% 31.88%
RCM R1 RCM Inc. Buy 4.45% -1%
CYH Community Health Systems, Inc. Buy 4.7% 1.38%
HQY HealthEquity, Inc. Buy 4.49% -3.16%
SAVA Cassava Sciences, Inc. Buy 5.46% 17.76%
SAGE Sage Therapeutics, Inc. Buy 4.55% -1.73%
HCSG Healthcare Services Group, Inc. Buy 4.46% -0.43%
RMD ResMed Inc. Buy 4.27% 0%
The percentage of cash held in the portfolio is: 10.54%
New Assets Added
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.76% 8.52%
OPK OPKO Health, Inc. Buy 4.76% 8.33%
ANGO AngioDynamics, Inc. Buy 5.48% 24.96%
SGRY Surgery Partners, Inc. Buy 5.34% 21.76%
AVNS Avanos Medical, Inc. Buy 4.74% 8.03%
CUTR Cutera, Inc. Buy 4.15% -5.41%
RGNX REGENXBIO Inc. Buy 4.95% 12.9%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.71% 7.37%
MASI Masimo Corporation Buy 4.21% -3.46%
BKD Brookdale Senior Living Inc. Buy 5.98% 4.37%
FATE Fate Therapeutics, Inc. Buy 7.96% 39.07%
RCM R1 RCM Inc. Buy 4.31% -2.61%
CLDX Celldex Therapeutics, Inc. Buy 4.38% -4.26%
SMTI Sanara MedTech Inc. Buy 4.32% -5.45%
CYH Community Health Systems, Inc. Buy 4.65% 1.77%
HQY HealthEquity, Inc. Buy 4.49% -1.69%
SAVA Cassava Sciences, Inc. Buy 5.51% 20.78%
SAGE Sage Therapeutics, Inc. Buy 4.49% -1.64%
HCSG Healthcare Services Group, Inc. Buy 4.41% 0%
The percentage of cash held in the portfolio is: 6.41%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.8% 10.23%
OPK OPKO Health, Inc. Buy 4.88% 12.12%
ANGO AngioDynamics, Inc. Buy 5.42% 24.8%
SGRY Surgery Partners, Inc. Buy 5.45% 25.32%
AVNS Avanos Medical, Inc. Buy 4.75% 9.25%
CUTR Cutera, Inc. Buy 4.46% 2.7%
RGNX REGENXBIO Inc. Buy 4.9% 12.75%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.69% 7.93%
MASI Masimo Corporation Buy 4.2% -2.65%
BKD Brookdale Senior Living Inc. Buy 6% 5.69%
FATE Fate Therapeutics, Inc. Buy 7.94% 39.85%
RCM R1 RCM Inc. Buy 4.38% -0.19%
PTGX Protagonist Therapeutics, Inc. Buy 4.36% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 4.61% 1.6%
SMTI Sanara MedTech Inc. Buy 4.53% 0%
CYH Community Health Systems, Inc. Buy 4.53% 0%
HQY HealthEquity, Inc. Buy 4.53% 0%
SAVA Cassava Sciences, Inc. Buy 4.53% 0%
SAGE Sage Therapeutics, Inc. Buy 4.53% 0%
The percentage of cash held in the portfolio is: 6.53%
New Assets Added
  • SMTI
  • CYH
  • HQY
  • SAVA
  • SAGE
Assets Removed
Asset Action Perf %
ATRC Sell All -12.65%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.9% 11.93%
OPK OPKO Health, Inc. Buy 4.71% 7.58%
ANGO AngioDynamics, Inc. Buy 5.36% 22.51%
SGRY Surgery Partners, Inc. Buy 5.27% 20.35%
AVNS Avanos Medical, Inc. Buy 4.73% 8.22%
CUTR Cutera, Inc. Buy 4.14% -5.41%
RGNX REGENXBIO Inc. Buy 4.95% 13.22%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.71% 7.69%
MASI Masimo Corporation Buy 4.26% -1.95%
BKD Brookdale Senior Living Inc. Buy 5.91% 3.44%
FATE Fate Therapeutics, Inc. Buy 7.93% 38.82%
ATRC AtriCure, Inc. Buy 4.81% -7%
RCM R1 RCM Inc. Buy 4.38% -0.84%
PTGX Protagonist Therapeutics, Inc. Buy 4.53% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 4.57% 0%
The percentage of cash held in the portfolio is: 24.83%
New Assets Added
  • CLDX
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.73% 6.96%
OPK OPKO Health, Inc. Buy 4.75% 7.58%
ANGO AngioDynamics, Inc. Buy 5.28% 19.58%
SGRY Surgery Partners, Inc. Buy 5.13% 16.16%
AVNS Avanos Medical, Inc. Buy 4.71% 6.7%
CUTR Cutera, Inc. Buy 4.3% -2.7%
RGNX REGENXBIO Inc. Buy 4.74% 7.32%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.72% 6.84%
MASI Masimo Corporation Buy 4.28% -2.4%
BKD Brookdale Senior Living Inc. Buy 5.98% 3.7%
FATE Fate Therapeutics, Inc. Buy 7.68% 33.16%
ATRC AtriCure, Inc. Buy 4.94% -5.18%
RCM R1 RCM Inc. Buy 4.5% 0.92%
PTGX Protagonist Therapeutics, Inc. Buy 4.61% 0%
The percentage of cash held in the portfolio is: 29.66%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
SAGE Sell All -11.55%
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.9% 10.8%
OPK OPKO Health, Inc. Buy 4.89% 10.61%
ANGO AngioDynamics, Inc. Buy 5.14% 16.31%
SGRY Surgery Partners, Inc. Buy 4.87% 10.29%
AVNS Avanos Medical, Inc. Buy 4.69% 6.28%
CUTR Cutera, Inc. Buy 4.86% 10.14%
RGNX REGENXBIO Inc. Buy 4.44% 0.47%
SAGE Sage Therapeutics, Inc. Buy 4.82% 9.08%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.65% 5.3%
MASI Masimo Corporation Buy 4.21% -4.03%
BKD Brookdale Senior Living Inc. Buy 5.93% 2.78%
FATE Fate Therapeutics, Inc. Buy 6.76% 17.22%
ATRC AtriCure, Inc. Buy 4.91% -5.85%
RCM R1 RCM Inc. Buy 4.56% 2.15%
The percentage of cash held in the portfolio is: 30.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Sell All 13.4%
RYTM Sell All 16.66%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 5.13% 9.54%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.44% 16.17%
PDSB PDS Biotechnology Corporation Buy 4.9% 9.94%
OPK OPKO Health, Inc. Buy 5.03% 12.88%
ANGO AngioDynamics, Inc. Buy 5.22% 17.13%
SGRY Surgery Partners, Inc. Buy 5.07% 13.7%
AVNS Avanos Medical, Inc. Buy 4.63% 3.82%
CUTR Cutera, Inc. Buy 4.79% 7.43%
RGNX REGENXBIO Inc. Buy 4.41% -1.02%
SAGE Sage Therapeutics, Inc. Buy 4.67% 4.73%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.73% 6.18%
MASI Masimo Corporation Buy 4.22% -4.64%
BKD Brookdale Senior Living Inc. Buy 5.89% 1.19%
FATE Fate Therapeutics, Inc. Buy 6.39% 9.77%
ATRC AtriCure, Inc. Buy 5.03% -4.47%
RCM R1 RCM Inc. Buy 4.59% 2%
The percentage of cash held in the portfolio is: 19.88%
New Assets Added
None
Assets Removed
Asset Action Perf %
TDOC Sell All -2.99%
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 5.13% 9.54%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.4% 15.44%
PDSB PDS Biotechnology Corporation Buy 4.89% 9.66%
ALT Altimmune, Inc. Buy 3.9% -12.43%
OPK OPKO Health, Inc. Buy 5.13% 15.15%
ANGO AngioDynamics, Inc. Buy 5.05% 13.38%
TDOC Teladoc Health, Inc. Buy 4.42% -0.64%
SGRY Surgery Partners, Inc. Buy 5.07% 13.89%
AVNS Avanos Medical, Inc. Buy 4.72% 5.95%
CUTR Cutera, Inc. Buy 4.66% 4.73%
RGNX REGENXBIO Inc. Buy 4.5% 1.1%
SAGE Sage Therapeutics, Inc. Buy 4.62% 3.71%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.55% 2.14%
MASI Masimo Corporation Buy 4.24% -4.06%
BKD Brookdale Senior Living Inc. Buy 5.91% 1.59%
FATE Fate Therapeutics, Inc. Buy 6.44% 10.8%
ATRC AtriCure, Inc. Buy 5.13% -2.49%
RCM R1 RCM Inc. Buy 4.43% -1.46%
The percentage of cash held in the portfolio is: 11.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All 17.81%
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 5.59% 23.12%
VRDN Viridian Therapeutics, Inc. Buy 5.23% 15.37%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.54% 22.05%
PDSB PDS Biotechnology Corporation Buy 4.92% 13.92%
ALT Altimmune, Inc. Buy 4.33% 0.13%
OPK OPKO Health, Inc. Buy 4.65% 7.58%
WST West Pharmaceutical Services, Inc. Buy 4.24% -1.88%
ANGO AngioDynamics, Inc. Buy 5.21% 20.72%
TDOC Teladoc Health, Inc. Buy 4.62% 7.04%
SGRY Surgery Partners, Inc. Buy 4.99% 15.66%
AVNS Avanos Medical, Inc. Buy 4.62% 6.89%
CUTR Cutera, Inc. Buy 4.87% 12.84%
RGNX REGENXBIO Inc. Buy 4.51% 4.48%
SAGE Sage Therapeutics, Inc. Buy 4.47% 3.54%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.39% 1.61%
MASI Masimo Corporation Buy 4.17% -2.67%
BKD Brookdale Senior Living Inc. Buy 5.77% 2.25%
FATE Fate Therapeutics, Inc. Buy 6.46% 14.65%
ATRC AtriCure, Inc. Buy 5.05% -0.91%
RCM R1 RCM Inc. Buy 4.36% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 5.6% 25%
VRDN Viridian Therapeutics, Inc. Buy 5.42% 20.89%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.66% 26.29%
PDSB PDS Biotechnology Corporation Buy 5.03% 17.76%
BHVN Biohaven Ltd. Buy 4.48% 4.86%
ALT Altimmune, Inc. Buy 4.62% 8.29%
OPK OPKO Health, Inc. Buy 4.66% 9.09%
WST West Pharmaceutical Services, Inc. Buy 4.21% -1.26%
ANGO AngioDynamics, Inc. Buy 5.23% 22.51%
TDOC Teladoc Health, Inc. Buy 4.59% 7.68%
SGRY Surgery Partners, Inc. Buy 4.65% 8.92%
AVNS Avanos Medical, Inc. Buy 4.44% 4.2%
CUTR Cutera, Inc. Buy 4.78% 12.16%
RGNX REGENXBIO Inc. Buy 4.55% 6.69%
SAGE Sage Therapeutics, Inc. Buy 4.42% 3.62%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.33% 1.58%
MASI Masimo Corporation Buy 4.16% -1.86%
BKD Brookdale Senior Living Inc. Buy 5.62% 0.93%
FATE Fate Therapeutics, Inc. Buy 6.51% 16.97%
ATRC AtriCure, Inc. Buy 5.04% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ATRC
Assets Removed
Asset Action Perf %
RARE Sell All 13.6%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
RARE Ultragenyx Pharmaceutical Inc. Buy 5.3% 11.57%
CYH Community Health Systems, Inc. Buy 5.74% 21.88%
VRDN Viridian Therapeutics, Inc. Buy 5.24% 11.2%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.73% 21.63%
PDSB PDS Biotechnology Corporation Buy 5.38% 20.03%
BHVN Biohaven Ltd. Buy 4.77% 6.27%
ALT Altimmune, Inc. Buy 4.74% 5.61%
OPK OPKO Health, Inc. Buy 4.86% 8.33%
WST West Pharmaceutical Services, Inc. Buy 4.3% -3.96%
ANGO AngioDynamics, Inc. Buy 4.33% -3.26%
TDOC Teladoc Health, Inc. Buy 4.43% -1.17%
SGRY Surgery Partners, Inc. Buy 4.51% 0.74%
AVNS Avanos Medical, Inc. Buy 4.43% -1.18%
CUTR Cutera, Inc. Buy 4.66% 4.05%
RGNX REGENXBIO Inc. Buy 4.54% 1.26%
SAGE Sage Therapeutics, Inc. Buy 4.51% 0.55%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.52% 0.84%
MASI Masimo Corporation Buy 4.33% -2.75%
BKD Brookdale Senior Living Inc. Buy 5.85% 0%
FATE Fate Therapeutics, Inc. Buy 5.85% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BKD
  • FATE
Assets Removed
Asset Action Perf %
ACAD Sell All 13.54%
EGRX Sell All 33.26%
Assets Rebalanced
None
2024-07-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.35% 11.9%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.43% 34.37%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.42% 13.27%
CYH Community Health Systems, Inc. Buy 5.63% 18.75%
VRDN Viridian Therapeutics, Inc. Buy 4.99% 5.15%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.56% 17.23%
PDSB PDS Biotechnology Corporation Buy 5.25% 16.19%
BHVN Biohaven Ltd. Buy 4.76% 5.28%
ALT Altimmune, Inc. Buy 4.77% 5.61%
OPK OPKO Health, Inc. Buy 4.72% 4.55%
WST West Pharmaceutical Services, Inc. Buy 4.37% -3.1%
ANGO AngioDynamics, Inc. Buy 4.42% -2.12%
TDOC Teladoc Health, Inc. Buy 4.52% 0.21%
SGRY Surgery Partners, Inc. Buy 4.75% 5.17%
AVNS Avanos Medical, Inc. Buy 4.49% -0.47%
CUTR Cutera, Inc. Buy 4.48% -0.68%
RGNX REGENXBIO Inc. Buy 4.54% 0.47%
SAGE Sage Therapeutics, Inc. Buy 4.52% 0.21%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.53% 0.46%
MASI Masimo Corporation Buy 4.48% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MASI
Assets Removed
None
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.4% 11.15%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.54% 34.6%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.35% 10.14%
CYH Community Health Systems, Inc. Buy 5.58% 15.94%
VRDN Viridian Therapeutics, Inc. Buy 4.72% -1.97%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.26% 9.21%
PDSB PDS Biotechnology Corporation Buy 5.06% 10.23%
BHVN Biohaven Ltd. Buy 4.81% 4.89%
ALT Altimmune, Inc. Buy 4.71% 2.67%
OPK OPKO Health, Inc. Buy 4.76% 3.79%
WST West Pharmaceutical Services, Inc. Buy 4.58% 0%
ANGO AngioDynamics, Inc. Buy 4.58% 0%
TDOC Teladoc Health, Inc. Buy 4.58% 0%
SGRY Surgery Partners, Inc. Buy 4.58% 0%
AVNS Avanos Medical, Inc. Buy 4.58% 0%
CUTR Cutera, Inc. Buy 4.58% 0%
RGNX REGENXBIO Inc. Buy 4.58% 0%
SAGE Sage Therapeutics, Inc. Buy 4.58% 0%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.58% 0%
The percentage of cash held in the portfolio is: 6.58%
New Assets Added
  • WST
  • ANGO
  • TDOC
  • SGRY
  • AVNS
  • CUTR
  • RGNX
  • SAGE
  • SUPN
Assets Removed
None
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.36% 7.75%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.71% 34.82%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.3% 6.55%
CYH Community Health Systems, Inc. Buy 5.15% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 4.58% -7.12%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.13% 4.01%
PDSB PDS Biotechnology Corporation Buy 4.7% 0%
BHVN Biohaven Ltd. Buy 4.7% 0%
ALT Altimmune, Inc. Buy 4.7% 0%
OPK OPKO Health, Inc. Buy 4.7% 0%
The percentage of cash held in the portfolio is: 48.98%
New Assets Added
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.36% 7.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.73% 35.49%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.27% 6.02%
CYH Community Health Systems, Inc. Buy 5.11% 3.75%
VRDN Viridian Therapeutics, Inc. Buy 4.6% -6.59%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.19% 5.32%
The percentage of cash held in the portfolio is: 67.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVRO Sell All -11.61%
Assets Rebalanced
None
2024-07-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.12% 2.77%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.68% 34.15%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.19% 4.12%
CYH Community Health Systems, Inc. Buy 5% 1.25%
NVRO Nevro Corp. Buy 4.8% -2.79%
VRDN Viridian Therapeutics, Inc. Buy 4.6% -6.81%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.07% 2.55%
The percentage of cash held in the portfolio is: 63.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
VERU Sell All -3.41%
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 4.93% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.16% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.07% 0.9%
CYH Community Health Systems, Inc. Buy 5.24% 5.31%
NVRO Nevro Corp. Buy 4.85% -2.67%
VRDN Viridian Therapeutics, Inc. Buy 4.62% -7.27%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.76% -4.36%
VERU Veru Inc. Buy 5.15% 3.41%
The percentage of cash held in the portfolio is: 59.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 4.98% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.83% 16.74%
STAA STAAR Surgical Company Buy 5.26% 5.2%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.14% 2.79%
CYH Community Health Systems, Inc. Buy 5.31% 7.19%
NVRO Nevro Corp. Buy 4.81% -3.02%
VRDN Viridian Therapeutics, Inc. Buy 4.56% -7.95%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.92% -0.77%
VERU Veru Inc. Buy 5.35% 7.95%
The percentage of cash held in the portfolio is: 53.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 4.9% 1.01%
MNKD MannKind Corporation Buy 4.55% -6.26%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.99% 23.44%
STAA STAAR Surgical Company Buy 5.44% 12.05%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.01% 3.19%
CYH Community Health Systems, Inc. Buy 4.99% 3.75%
ARDX Ardelyx, Inc. Buy 4.91% 2.16%
CHRS Coherus BioSciences, Inc. Buy 4.48% -6.94%
NVRO Nevro Corp. Buy 4.81% 0%
VRDN Viridian Therapeutics, Inc. Buy 4.81% 0%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.81% 0%
VERU Veru Inc. Buy 4.81% 0%
The percentage of cash held in the portfolio is: 40.49%
New Assets Added
  • NVRO
  • VRDN
  • RYTM
  • VERU
Assets Removed
None
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 4.94% 2.33%
MNKD MannKind Corporation Buy 4.64% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.03% 25%
STAA STAAR Surgical Company Buy 5.43% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 4.98% 3.14%
CYH Community Health Systems, Inc. Buy 5.02% 5%
ARDX Ardelyx, Inc. Buy 4.78% 0%
CHRS Coherus BioSciences, Inc. Buy 4.78% 0%
The percentage of cash held in the portfolio is: 59.4%
New Assets Added
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.01% 3.09%
MNKD MannKind Corporation Buy 4.74% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.45% 12.05%
STAA STAAR Surgical Company Buy 5.38% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 5.06% 3.94%
CYH Community Health Systems, Inc. Buy 4.82% 0%
The percentage of cash held in the portfolio is: 69.54%
New Assets Added
  • CYH
Assets Removed
None
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 4.78% -2.39%
MNKD MannKind Corporation Buy 4.68% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.38% 9.82%
STAA STAAR Surgical Company Buy 5.27% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 4.98% 1.71%
The percentage of cash held in the portfolio is: 74.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 4.83% -1.76%
MNKD MannKind Corporation Buy 4.74% -3.5%
FGEN FibroGen, Inc. Buy 4.79% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 4.99% 1.56%
STAA STAAR Surgical Company Buy 4.92% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 4.92% 0%
The percentage of cash held in the portfolio is: 70.81%
New Assets Added
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 4.9% 0%
MNKD MannKind Corporation Buy 4.9% 0%
FGEN FibroGen, Inc. Buy 4.9% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-06-06 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCM Sell All 2%
Assets Rebalanced
None
2024-06-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 4.6% 2.32%
The percentage of cash held in the portfolio is: 95.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVXL Sell All 0.75%
EDIT Sell All -5.25%
Assets Rebalanced
None
2024-05-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
AVXL Anavex Life Sciences Corp. Buy 4.72% 0.25%
EDIT Editas Medicine, Inc. Buy 4.64% -1.4%
RCM R1 RCM Inc. Buy 4.49% -0.16%
The percentage of cash held in the portfolio is: 86.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
ABUS Sell All NA
Assets Rebalanced
None
2024-05-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ABUS Arbutus Biopharma Corporation Buy 5.73% 17.5%
AVXL Anavex Life Sciences Corp. Buy 4.72% 0.25%
EDIT Editas Medicine, Inc. Buy 4.64% -1.4%
RCM R1 RCM Inc. Buy 4.49% -0.16%
The percentage of cash held in the portfolio is: 80.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMCL Sell All 8.3%
NUTX Sell All 9.74%
AORT Sell All 13.62%
Assets Rebalanced
None
2024-05-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 5.13% 5.21%
NUTX Nutex Health Inc. Buy 5.3% 8.86%
AORT Artivion, Inc. Buy 5.5% 13%
ABUS Arbutus Biopharma Corporation Buy 5.71% 17.14%
AVXL Anavex Life Sciences Corp. Buy 4.92% 4.51%
EDIT Editas Medicine, Inc. Buy 4.8% 2.1%
RCM R1 RCM Inc. Buy 4.36% -2.92%
The percentage of cash held in the portfolio is: 64.27%
New Assets Added
None
Assets Removed
Asset Action Perf %
GKOS Sell All 2.29%
KIDS Sell All -0.25%
ALT Sell All 2.78%
VCYT Sell All -7.38%
Assets Rebalanced
None
2024-05-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
GKOS Glaukos Corporation Buy 4.82% 2.57%
KIDS OrthoPediatrics Corp. Buy 4.89% 4.21%
ALT Altimmune, Inc. Buy 5.15% 9.74%
OMCL Omnicell, Inc. Buy 5.13% 7%
NUTX Nutex Health Inc. Buy 5.15% 7.38%
AORT Artivion, Inc. Buy 5.45% 13.52%
ABUS Arbutus Biopharma Corporation Buy 5.85% 21.79%
VCYT Veracyte, Inc. Buy 4.45% -3.91%
AVXL Anavex Life Sciences Corp. Buy 5.23% 12.78%
EDIT Editas Medicine, Inc. Buy 4.89% 5.43%
RCM R1 RCM Inc. Buy 4.3% -2.72%
The percentage of cash held in the portfolio is: 44.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All -2.32%
INGN Sell All 22.55%
ACRS Sell All -8.73%
SGMO Sell All 18.52%
Assets Rebalanced
None
2024-05-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 5.81% 22.13%
ACRS Aclaris Therapeutics, Inc. Buy 4.46% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 5.29% 11.11%
GKOS Glaukos Corporation Buy 4.92% 3.33%
KIDS OrthoPediatrics Corp. Buy 4.93% 3.62%
ALT Altimmune, Inc. Buy 5.1% 7.09%
OMCL Omnicell, Inc. Buy 5.15% 5.91%
NUTX Nutex Health Inc. Buy 5.21% 7.24%
AORT Artivion, Inc. Buy 5.45% 12.09%
ABUS Arbutus Biopharma Corporation Buy 5.58% 14.64%
VCYT Veracyte, Inc. Buy 4.55% -3.2%
AVXL Anavex Life Sciences Corp. Buy 5.12% 9.02%
EDIT Editas Medicine, Inc. Buy 4.53% -3.5%
RCM R1 RCM Inc. Buy 4.41% -1.76%
PODD Insulet Corporation Buy 4.22% -1.4%
The percentage of cash held in the portfolio is: 25.29%
New Assets Added
None
Assets Removed
Asset Action Perf %
SENS Sell All -3.49%
Assets Rebalanced
None
2024-05-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
SENS Senseonics Holdings, Inc. Buy 4.57% -3.7%
INGN Inogen, Inc. Buy 5.9% 24.26%
ACRS Aclaris Therapeutics, Inc. Buy 4.48% -5.56%
SGMO Sangamo Therapeutics, Inc. Buy 5.36% 12.96%
GKOS Glaukos Corporation Buy 4.94% 4.04%
KIDS OrthoPediatrics Corp. Buy 4.85% 2.26%
ALT Altimmune, Inc. Buy 5.31% 11.82%
OMCL Omnicell, Inc. Buy 4.95% 1.99%
NUTX Nutex Health Inc. Buy 5.15% 6.21%
AORT Artivion, Inc. Buy 5.52% 13.76%
ABUS Arbutus Biopharma Corporation Buy 5.33% 9.64%
VCYT Veracyte, Inc. Buy 4.64% -0.89%
AVXL Anavex Life Sciences Corp. Buy 5.2% 11.03%
EDIT Editas Medicine, Inc. Buy 4.53% -3.33%
RCM R1 RCM Inc. Buy 4.38% -2.08%
PODD Insulet Corporation Buy 4.24% -0.67%
The percentage of cash held in the portfolio is: 20.65%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -0.79%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 4.68% -0.79%
SENS Senseonics Holdings, Inc. Buy 4.7% -0.41%
INGN Inogen, Inc. Buy 5.91% 25.25%
ACRS Aclaris Therapeutics, Inc. Buy 4.46% -5.56%
SGMO Sangamo Therapeutics, Inc. Buy 5.68% 20.37%
GKOS Glaukos Corporation Buy 4.93% 4.53%
KIDS OrthoPediatrics Corp. Buy 4.75% 0.66%
ALT Altimmune, Inc. Buy 5.26% 11.4%
OMCL Omnicell, Inc. Buy 4.87% 1.03%
NUTX Nutex Health Inc. Buy 5.05% 4.74%
AORT Artivion, Inc. Buy 5.4% 12.09%
ABUS Arbutus Biopharma Corporation Buy 5.14% 6.43%
VCYT Veracyte, Inc. Buy 4.73% 1.69%
AVXL Anavex Life Sciences Corp. Buy 5.31% 14.04%
EDIT Editas Medicine, Inc. Buy 4.58% -1.58%
RCM R1 RCM Inc. Buy 4.42% -0.56%
PODD Insulet Corporation Buy 4.28% 1.02%
The percentage of cash held in the portfolio is: 15.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
IBRX Sell All -14.91%
PTCT Sell All 15.84%
RYTM Sell All -8.38%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.54% 19.11%
IBRX ImmunityBio, Inc. Buy 4.01% -13.79%
CARA Cara Therapeutics, Inc. Buy 4.95% 6.48%
SENS Senseonics Holdings, Inc. Buy 4.7% 1.03%
INGN Inogen, Inc. Buy 5.91% 26.95%
ACRS Aclaris Therapeutics, Inc. Buy 4.36% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 5.26% 12.96%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.4% -5.45%
GKOS Glaukos Corporation Buy 4.89% 5.12%
KIDS OrthoPediatrics Corp. Buy 4.65% -0.06%
ALT Altimmune, Inc. Buy 5.76% 23.78%
OMCL Omnicell, Inc. Buy 4.99% 5.08%
NUTX Nutex Health Inc. Buy 5.15% 8.41%
AORT Artivion, Inc. Buy 5.34% 12.28%
ABUS Arbutus Biopharma Corporation Buy 4.91% 3.21%
VCYT Veracyte, Inc. Buy 4.77% 4%
AVXL Anavex Life Sciences Corp. Buy 5.18% 12.78%
EDIT Editas Medicine, Inc. Buy 4.74% 3.15%
RCM R1 RCM Inc. Buy 4.32% -1.52%
PODD Insulet Corporation Buy 4.18% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PODD
Assets Removed
Asset Action Perf %
MD Sell All -8.68%
Assets Rebalanced
None
2024-05-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.51% 17.82%
IBRX ImmunityBio, Inc. Buy 4.22% -9.9%
CARA Cara Therapeutics, Inc. Buy 4.7% 0.53%
SENS Senseonics Holdings, Inc. Buy 4.77% 1.85%
INGN Inogen, Inc. Buy 5.86% 25.39%
ACRS Aclaris Therapeutics, Inc. Buy 4.38% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 5.02% 7.41%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.47% -4.42%
GKOS Glaukos Corporation Buy 4.96% 6.06%
KIDS OrthoPediatrics Corp. Buy 4.61% -1.38%
ALT Altimmune, Inc. Buy 5.77% 23.37%
OMCL Omnicell, Inc. Buy 4.74% -0.86%
NUTX Nutex Health Inc. Buy 5.05% 5.62%
AORT Artivion, Inc. Buy 5.42% 13.38%
ABUS Arbutus Biopharma Corporation Buy 4.8% 0.36%
MD Pediatrix Medical Group, Inc. Buy 4.44% -3.87%
VCYT Veracyte, Inc. Buy 4.83% 4.67%
AVXL Anavex Life Sciences Corp. Buy 5.19% 12.53%
EDIT Editas Medicine, Inc. Buy 4.85% 5.08%
RCM R1 RCM Inc. Buy 4.41% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
WST Sell All -4.6%
Assets Rebalanced
None
2024-05-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.34% 10.96%
IBRX ImmunityBio, Inc. Buy 4.62% -4%
CARA Cara Therapeutics, Inc. Buy 4.77% -0.79%
SENS Senseonics Holdings, Inc. Buy 4.38% -8.83%
INGN Inogen, Inc. Buy 6.01% 25.04%
ACRS Aclaris Therapeutics, Inc. Buy 4.5% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 4.9% 1.85%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.66% -2.97%
GKOS Glaukos Corporation Buy 4.96% 3.17%
WST West Pharmaceutical Services, Inc. Buy 4.67% -2.79%
KIDS OrthoPediatrics Corp. Buy 4.7% -2.14%
ALT Altimmune, Inc. Buy 4.93% 2.5%
OMCL Omnicell, Inc. Buy 5.02% 2.22%
NUTX Nutex Health Inc. Buy 5.05% 2.82%
AORT Artivion, Inc. Buy 5.44% 10.85%
ABUS Arbutus Biopharma Corporation Buy 5.08% 3.21%
MD Pediatrix Medical Group, Inc. Buy 4.74% 0%
VCYT Veracyte, Inc. Buy 4.74% 0%
AVXL Anavex Life Sciences Corp. Buy 4.74% 0%
EDIT Editas Medicine, Inc. Buy 4.74% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
  • VCYT
  • AVXL
  • EDIT
Assets Removed
None
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.48% 12.88%
IBRX ImmunityBio, Inc. Buy 4.39% -9.68%
CARA Cara Therapeutics, Inc. Buy 4.6% -5.29%
SENS Senseonics Holdings, Inc. Buy 4.65% -4.31%
INGN Inogen, Inc. Buy 5.82% 20%
ACRS Aclaris Therapeutics, Inc. Buy 4.51% -7.14%
SGMO Sangamo Therapeutics, Inc. Buy 5.03% 3.7%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.59% -5.53%
GKOS Glaukos Corporation Buy 5.1% 5.17%
WST West Pharmaceutical Services, Inc. Buy 4.8% -1.16%
KIDS OrthoPediatrics Corp. Buy 4.74% -2.26%
ALT Altimmune, Inc. Buy 4.87% 0.42%
OMCL Omnicell, Inc. Buy 4.96% -0.03%
NUTX Nutex Health Inc. Buy 4.6% -7.18%
AORT Artivion, Inc. Buy 5.57% 12.42%
ABUS Arbutus Biopharma Corporation Buy 5.11% 2.86%
The percentage of cash held in the portfolio is: 21.18%
New Assets Added
None
Assets Removed
Asset Action Perf %
IOVA Sell All -12.24%
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.17% 8.68%
IBRX ImmunityBio, Inc. Buy 4.27% -10.34%
CARA Cara Therapeutics, Inc. Buy 4.79% 0.53%
SENS Senseonics Holdings, Inc. Buy 4.7% -1.23%
INGN Inogen, Inc. Buy 5.87% 23.26%
ACRS Aclaris Therapeutics, Inc. Buy 4.63% -2.78%
IOVA Iovance Biotherapeutics, Inc. Buy 5.12% 7.6%
SGMO Sangamo Therapeutics, Inc. Buy 4.58% -3.7%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.42% -7.07%
GKOS Glaukos Corporation Buy 4.88% 2.47%
WST West Pharmaceutical Services, Inc. Buy 4.72% -0.78%
KIDS OrthoPediatrics Corp. Buy 5.01% 5.28%
ALT Altimmune, Inc. Buy 5.11% 7.37%
OMCL Omnicell, Inc. Buy 4.88% 0.4%
NUTX Nutex Health Inc. Buy 4.72% -2.91%
AORT Artivion, Inc. Buy 5.44% 11.8%
ABUS Arbutus Biopharma Corporation Buy 5.11% 5%
The percentage of cash held in the portfolio is: 16.59%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Sell All 7.67%
Assets Rebalanced
None
2024-05-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.26% 9%
IBRX ImmunityBio, Inc. Buy 4.25% -11.9%
CDMO Avid Bioservices, Inc. Buy 5.35% 10.85%
CARA Cara Therapeutics, Inc. Buy 4.68% -3.04%
SENS Senseonics Holdings, Inc. Buy 4.72% -2.26%
INGN Inogen, Inc. Buy 5.64% 16.88%
ACRS Aclaris Therapeutics, Inc. Buy 4.67% -3.17%
IOVA Iovance Biotherapeutics, Inc. Buy 5.17% 7.12%
SGMO Sangamo Therapeutics, Inc. Buy 4.47% -7.41%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.53% -6.06%
GKOS Glaukos Corporation Buy 4.91% 1.79%
WST West Pharmaceutical Services, Inc. Buy 4.8% -0.49%
KIDS OrthoPediatrics Corp. Buy 5.03% 4.31%
ALT Altimmune, Inc. Buy 4.8% -0.42%
OMCL Omnicell, Inc. Buy 4.9% -0.56%
NUTX Nutex Health Inc. Buy 4.69% -4.82%
AORT Artivion, Inc. Buy 5.49% 11.32%
ABUS Arbutus Biopharma Corporation Buy 5.01% 1.43%
The percentage of cash held in the portfolio is: 11.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLUE Sell All -3%
PEN Sell All -2.62%
Assets Rebalanced
None
2024-05-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.48% 15.37%
IBRX ImmunityBio, Inc. Buy 4.13% -13.13%
CDMO Avid Bioservices, Inc. Buy 5.29% 11.38%
CARA Cara Therapeutics, Inc. Buy 4.96% 4.5%
SENS Senseonics Holdings, Inc. Buy 4.92% 3.49%
INGN Inogen, Inc. Buy 4.84% 1.99%
ACRS Aclaris Therapeutics, Inc. Buy 4.94% 3.97%
IOVA Iovance Biotherapeutics, Inc. Buy 5.27% 11.04%
SGMO Sangamo Therapeutics, Inc. Buy 4.66% -1.85%
RYTM Rhythm Pharmaceuticals, Inc. Buy 5.03% 5.91%
GKOS Glaukos Corporation Buy 4.75% -0.02%
WST West Pharmaceutical Services, Inc. Buy 4.72% -0.52%
KIDS OrthoPediatrics Corp. Buy 5.01% 5.63%
ALT Altimmune, Inc. Buy 4.86% 2.36%
OMCL Omnicell, Inc. Buy 4.83% -0.5%
NUTX Nutex Health Inc. Buy 4.8% -1%
AORT Artivion, Inc. Buy 4.88% 0.67%
PEN Penumbra, Inc. Buy 4.92% 1.47%
ABUS Arbutus Biopharma Corporation Buy 4.86% 0%
BLUE bluebird bio, Inc. Buy 4.86% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ABUS
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.45% 15.54%
IBRX ImmunityBio, Inc. Buy 4.8% 1.78%
CDMO Avid Bioservices, Inc. Buy 5.15% 9.13%
CARA Cara Therapeutics, Inc. Buy 4.86% 2.94%
SENS Senseonics Holdings, Inc. Buy 4.89% 3.68%
INGN Inogen, Inc. Buy 4.78% 1.42%
ACRS Aclaris Therapeutics, Inc. Buy 5.09% 7.94%
IOVA Iovance Biotherapeutics, Inc. Buy 5.14% 9.04%
SGMO Sangamo Therapeutics, Inc. Buy 4.85% 2.93%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.98% 5.62%
GKOS Glaukos Corporation Buy 4.78% 1.41%
WST West Pharmaceutical Services, Inc. Buy 4.67% -0.93%
KIDS OrthoPediatrics Corp. Buy 4.87% 3.21%
ALT Altimmune, Inc. Buy 4.79% 1.53%
OMCL Omnicell, Inc. Buy 4.82% 0%
NUTX Nutex Health Inc. Buy 4.82% 0%
AORT Artivion, Inc. Buy 4.82% 0%
PEN Penumbra, Inc. Buy 4.82% 0%
The percentage of cash held in the portfolio is: 11.63%
New Assets Added
  • OMCL
  • NUTX
  • AORT
  • PEN
Assets Removed
Asset Action Perf %
SMMT Sell All 13.73%
Assets Rebalanced
None
2024-05-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.65% 17.68%
SMMT Summit Therapeutics Inc. Buy 5.05% 5.18%
IBRX ImmunityBio, Inc. Buy 4.79% -0.22%
CDMO Avid Bioservices, Inc. Buy 5.21% 8.47%
CARA Cara Therapeutics, Inc. Buy 4.9% 2.12%
SENS Senseonics Holdings, Inc. Buy 5.11% 6.37%
INGN Inogen, Inc. Buy 4.79% -0.28%
ACRS Aclaris Therapeutics, Inc. Buy 4.99% 3.97%
IOVA Iovance Biotherapeutics, Inc. Buy 4.95% 3.04%
SGMO Sangamo Therapeutics, Inc. Buy 4.62% -3.7%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.75% -1.09%
GKOS Glaukos Corporation Buy 4.8% 0%
WST West Pharmaceutical Services, Inc. Buy 4.8% 0%
KIDS OrthoPediatrics Corp. Buy 4.8% 0%
ALT Altimmune, Inc. Buy 4.8% 0%
The percentage of cash held in the portfolio is: 26%
New Assets Added
  • GKOS
  • WST
  • KIDS
  • ALT
Assets Removed
None
Assets Rebalanced
None
2024-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.76% 19.57%
SMMT Summit Therapeutics Inc. Buy 5.87% 21.76%
IBRX ImmunityBio, Inc. Buy 4.58% -5.01%
CDMO Avid Bioservices, Inc. Buy 4.89% 1.46%
CARA Cara Therapeutics, Inc. Buy 4.84% 0.4%
SENS Senseonics Holdings, Inc. Buy 4.58% -4.93%
INGN Inogen, Inc. Buy 4.82% 0%
ACRS Aclaris Therapeutics, Inc. Buy 4.82% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 4.82% 0%
SGMO Sangamo Therapeutics, Inc. Buy 4.82% 0%
RYTM Rhythm Pharmaceuticals, Inc. Buy 4.82% 0%
The percentage of cash held in the portfolio is: 45.37%
New Assets Added
  • INGN
  • ACRS
  • IOVA
  • SGMO
  • RYTM
Assets Removed
None
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.5% 12.53%
SMMT Summit Therapeutics Inc. Buy 4.98% 1.81%
IBRX ImmunityBio, Inc. Buy 4.35% -11.12%
CDMO Avid Bioservices, Inc. Buy 4.94% 0.93%
CARA Cara Therapeutics, Inc. Buy 4.86% -0.53%
SENS Senseonics Holdings, Inc. Buy 4.89% 0%
The percentage of cash held in the portfolio is: 70.48%
New Assets Added
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 5.48% 12.5%
SMMT Summit Therapeutics Inc. Buy 4.89% 0.52%
IBRX ImmunityBio, Inc. Buy 4.87% 0%
CDMO Avid Bioservices, Inc. Buy 4.87% 0%
CARA Cara Therapeutics, Inc. Buy 4.87% 0%
The percentage of cash held in the portfolio is: 75.02%
New Assets Added
  • IBRX
  • CDMO
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 4.9% 0%
SMMT Summit Therapeutics Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • PTCT
  • SMMT
Assets Removed
None
Assets Rebalanced
None
2024-04-23 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All -6.11%
Assets Rebalanced
None
2024-04-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 4.75% -4.58%
The percentage of cash held in the portfolio is: 95.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
ANGO Sell All 11.05%
KIDS Sell All 3.21%
ACRS Sell All -2.38%
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.58% 10.7%
KIDS OrthoPediatrics Corp. Buy 5.3% 5.11%
ACRS Aclaris Therapeutics, Inc. Buy 4.84% -3.97%
OPK OPKO Health, Inc. Buy 4.68% -6.11%
The percentage of cash held in the portfolio is: 79.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All -9.75%
Assets Rebalanced
None
2024-04-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.61% 11.75%
TNDM Tandem Diabetes Care, Inc. Buy 4.76% -5.1%
KIDS OrthoPediatrics Corp. Buy 5.39% 7.32%
ACRS Aclaris Therapeutics, Inc. Buy 4.82% -3.97%
OPK OPKO Health, Inc. Buy 4.66% -6.11%
The percentage of cash held in the portfolio is: 74.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
RVNC Sell All -16.06%
Assets Rebalanced
None
2024-04-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.98% 20.18%
TNDM Tandem Diabetes Care, Inc. Buy 4.87% -2.07%
KIDS OrthoPediatrics Corp. Buy 5.45% 9.67%
ACRS Aclaris Therapeutics, Inc. Buy 4.58% -7.94%
RVNC Revance Therapeutics, Inc. Buy 4.46% -10.37%
OPK OPKO Health, Inc. Buy 4.77% -3.05%
The percentage of cash held in the portfolio is: 69.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Sell All -15.83%
Assets Rebalanced
None
2024-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.43% 8.6%
TNDM Tandem Diabetes Care, Inc. Buy 4.75% -5.1%
KIDS OrthoPediatrics Corp. Buy 4.61% -7.9%
ACRS Aclaris Therapeutics, Inc. Buy 4.84% -3.17%
RVNC Revance Therapeutics, Inc. Buy 4.58% -8.33%
LXRX Lexicon Pharmaceuticals, Inc. Buy 4.61% -7.92%
OPK OPKO Health, Inc. Buy 5.1% 3.05%
The percentage of cash held in the portfolio is: 66.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -5.57%
Assets Rebalanced
None
2024-04-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.08% 2.28%
TNDM Tandem Diabetes Care, Inc. Buy 4.77% -4.11%
KIDS OrthoPediatrics Corp. Buy 4.84% -2.69%
ACRS Aclaris Therapeutics, Inc. Buy 4.97% 0%
VCYT Veracyte, Inc. Buy 4.95% -0.37%
RVNC Revance Therapeutics, Inc. Buy 4.78% -3.86%
LXRX Lexicon Pharmaceuticals, Inc. Buy 4.72% -5%
OPK OPKO Health, Inc. Buy 4.91% 0%
The percentage of cash held in the portfolio is: 60.98%
New Assets Added
  • OPK
Assets Removed
Asset Action Perf %
OFIX Sell All -3.17%
ATRI Sell All -11.81%
Assets Rebalanced
None
2024-03-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.04% 2.98%
TNDM Tandem Diabetes Care, Inc. Buy 4.9% 0.31%
KIDS OrthoPediatrics Corp. Buy 4.92% 0.66%
ACRS Aclaris Therapeutics, Inc. Buy 4.81% -1.59%
VCYT Veracyte, Inc. Buy 4.99% 2.03%
ATRI Atrion Corporation Buy 4.89% 0%
OFIX Orthofix Medical Inc. Buy 4.89% 0%
RVNC Revance Therapeutics, Inc. Buy 4.89% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 4.89% 0%
The percentage of cash held in the portfolio is: 55.78%
New Assets Added
  • ATRI
  • OFIX
  • RVNC
  • LXRX
Assets Removed
None
Assets Rebalanced
None
2024-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 4.9% 0%
TNDM Tandem Diabetes Care, Inc. Buy 4.9% 0%
KIDS OrthoPediatrics Corp. Buy 4.9% 0%
ACRS Aclaris Therapeutics, Inc. Buy 4.9% 0%
VCYT Veracyte, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 75.5%
New Assets Added
  • ANGO
  • TNDM
  • KIDS
  • ACRS
  • VCYT
Assets Removed
Asset Action Perf %
BAX Sell All -0.7%
OMCL Sell All 5.22%
ADMA Sell All 10.13%
PCRX Sell All -3.55%
Assets Rebalanced
None
2024-03-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 4.6% -2.79%
OMCL Omnicell, Inc. Buy 4.84% 2.2%
ADMA ADMA Biologics, Inc. Buy 4.95% 4.41%
PCRX Pacira BioSciences, Inc. Buy 4.6% -2.92%
The percentage of cash held in the portfolio is: 81.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
BHVN Sell All -2.06%
RGNX Sell All 1.08%
Assets Rebalanced
None
2024-03-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
BHVN Biohaven Ltd. Buy 5.03% -0.96%
RGNX REGENXBIO Inc. Buy 5.18% 1.97%
BAX Baxter International Inc. Buy 4.63% -2.44%
OMCL Omnicell, Inc. Buy 4.77% 0.5%
ADMA ADMA Biologics, Inc. Buy 4.87% 2.78%
PCRX Pacira BioSciences, Inc. Buy 4.52% -4.78%
The percentage of cash held in the portfolio is: 71.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
THC Sell All 8.23%
RDNT Sell All 8.32%
NTRA Sell All 3.25%
Assets Rebalanced
None
2024-03-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 5.56% 8.8%
RDNT RadNet, Inc. Buy 5.44% 6.45%
NTRA Natera, Inc. Buy 5.31% 3.9%
BHVN Biohaven Ltd. Buy 5.31% 5.27%
RGNX REGENXBIO Inc. Buy 5.32% 5.38%
BAX Baxter International Inc. Buy 4.58% -2.7%
OMCL Omnicell, Inc. Buy 4.73% 0.5%
ADMA ADMA Biologics, Inc. Buy 4.86% 3.27%
PCRX Pacira BioSciences, Inc. Buy 4.7% -0.3%
The percentage of cash held in the portfolio is: 54.18%
New Assets Added
None
Assets Removed
Asset Action Perf %
QTRX Sell All -9.55%
Assets Rebalanced
None
2024-03-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 5.5% 6.46%
RDNT RadNet, Inc. Buy 5.23% 1.08%
NTRA Natera, Inc. Buy 5.21% 0.79%
QTRX Quanterix Corporation Buy 4.83% -5.31%
BHVN Biohaven Ltd. Buy 5.13% 0.62%
RGNX REGENXBIO Inc. Buy 5.33% 4.54%
BAX Baxter International Inc. Buy 4.6% -3.37%
OMCL Omnicell, Inc. Buy 4.71% -1.15%
ADMA ADMA Biologics, Inc. Buy 4.62% -2.94%
PCRX Pacira BioSciences, Inc. Buy 4.63% -2.72%
The percentage of cash held in the portfolio is: 50.18%
New Assets Added
None
Assets Removed
Asset Action Perf %
ABUS Sell All -5.93%
Assets Rebalanced
None
2024-03-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 5.41% 4.78%
RDNT RadNet, Inc. Buy 5.18% 0.23%
NTRA Natera, Inc. Buy 5.17% 0.12%
QTRX Quanterix Corporation Buy 4.82% -5.42%
BHVN Biohaven Ltd. Buy 5.16% 1.21%
RGNX REGENXBIO Inc. Buy 5.3% 3.89%
BAX Baxter International Inc. Buy 4.61% -3.21%
OMCL Omnicell, Inc. Buy 4.74% -0.36%
ADMA ADMA Biologics, Inc. Buy 4.66% -2.12%
PCRX Pacira BioSciences, Inc. Buy 4.65% -2.32%
ABUS Arbutus Biopharma Corporation Buy 5.07% -2.96%
The percentage of cash held in the portfolio is: 45.23%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTGX Sell All 1.76%
Assets Rebalanced
None
2024-03-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 4.75% -0.46%
THC Tenet Healthcare Corporation Buy 5.5% 6.1%
RDNT RadNet, Inc. Buy 5.13% -1.08%
NTRA Natera, Inc. Buy 5.09% -1.9%
QTRX Quanterix Corporation Buy 4.81% -6.02%
BHVN Biohaven Ltd. Buy 5.12% 0.05%
RGNX REGENXBIO Inc. Buy 5.24% 2.29%
BAX Baxter International Inc. Buy 4.67% -2.26%
OMCL Omnicell, Inc. Buy 4.74% -0.72%
ADMA ADMA Biologics, Inc. Buy 4.7% -1.63%
PCRX Pacira BioSciences, Inc. Buy 4.64% -2.82%
ABUS Arbutus Biopharma Corporation Buy 5.07% -3.33%
The percentage of cash held in the portfolio is: 40.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -15.74%
Assets Rebalanced
None
2024-03-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 4.89% 4.88%
THC Tenet Healthcare Corporation Buy 5.38% 6.01%
MRSN Mersana Therapeutics, Inc. Buy 4.82% -5.05%
RDNT RadNet, Inc. Buy 5.26% 3.77%
NTRA Natera, Inc. Buy 5.15% 1.57%
QTRX Quanterix Corporation Buy 4.78% -4.49%
BHVN Biohaven Ltd. Buy 5.2% 3.88%
RGNX REGENXBIO Inc. Buy 5.15% 2.9%
BAX Baxter International Inc. Buy 4.66% -0.23%
OMCL Omnicell, Inc. Buy 4.72% 1.04%
ADMA ADMA Biologics, Inc. Buy 4.75% 1.63%
PCRX Pacira BioSciences, Inc. Buy 4.74% 1.49%
ABUS Arbutus Biopharma Corporation Buy 5.11% -0.37%
The percentage of cash held in the portfolio is: 35.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Sell All -5.28%
APLS Sell All -9.48%
TVTX Sell All -9.99%
Assets Rebalanced
None
2024-03-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 4.91% 5.76%
THC Tenet Healthcare Corporation Buy 5.2% 2.95%
MRSN Mersana Therapeutics, Inc. Buy 4.84% -4.21%
ENTA Enanta Pharmaceuticals, Inc. Buy 4.96% -1.76%
RDNT RadNet, Inc. Buy 5.27% 4.24%
NTRA Natera, Inc. Buy 5.05% -0.15%
QTRX Quanterix Corporation Buy 4.68% -6.13%
BHVN Biohaven Ltd. Buy 4.9% -1.79%
RGNX REGENXBIO Inc. Buy 5.33% 6.98%
APLS Apellis Pharmaceuticals, Inc. Buy 4.68% -6.1%
BAX Baxter International Inc. Buy 4.71% 1.14%
OMCL Omnicell, Inc. Buy 4.74% 1.76%
ADMA ADMA Biologics, Inc. Buy 4.7% 0.98%
TVTX Travere Therapeutics, Inc. Buy 4.32% -7.2%
PCRX Pacira BioSciences, Inc. Buy 4.8% 3.02%
ABUS Arbutus Biopharma Corporation Buy 5.15% 0.74%
The percentage of cash held in the portfolio is: 21.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACRS Sell All 3.2%
Assets Rebalanced
None
2024-03-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 4.86% 6.46%
THC Tenet Healthcare Corporation Buy 5.2% 4.66%
MRSN Mersana Therapeutics, Inc. Buy 4.83% -2.69%
ENTA Enanta Pharmaceuticals, Inc. Buy 4.98% 0.33%
RDNT RadNet, Inc. Buy 5.21% 4.87%
NTRA Natera, Inc. Buy 4.95% -0.39%
QTRX Quanterix Corporation Buy 4.63% -5.45%
BHVN Biohaven Ltd. Buy 5.04% 2.8%
RGNX REGENXBIO Inc. Buy 5.22% 6.51%
ACRS Aclaris Therapeutics, Inc. Buy 5.53% 12.8%
APLS Apellis Pharmaceuticals, Inc. Buy 4.67% -4.64%
BAX Baxter International Inc. Buy 4.66% 1.81%
OMCL Omnicell, Inc. Buy 4.7% 2.73%
ADMA ADMA Biologics, Inc. Buy 4.74% 3.59%
TVTX Travere Therapeutics, Inc. Buy 4.6% 0.58%
PCRX Pacira BioSciences, Inc. Buy 4.77% 4.32%
ABUS Arbutus Biopharma Corporation Buy 5.08% 1.11%
The percentage of cash held in the portfolio is: 16.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
CERS Sell All -6.61%
Assets Rebalanced
None
2024-03-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 4.92% 8.46%
THC Tenet Healthcare Corporation Buy 5.14% 4.1%
MRSN Mersana Therapeutics, Inc. Buy 4.86% -1.52%
ENTA Enanta Pharmaceuticals, Inc. Buy 5.05% 2.41%
RDNT RadNet, Inc. Buy 5.4% 9.45%
NTRA Natera, Inc. Buy 5.06% 2.52%
QTRX Quanterix Corporation Buy 4.87% -0.07%
BHVN Biohaven Ltd. Buy 5.01% 2.94%
RGNX REGENXBIO Inc. Buy 5.3% 8.75%
ACRS Aclaris Therapeutics, Inc. Buy 5.26% 8%
APLS Apellis Pharmaceuticals, Inc. Buy 4.71% -3.39%
BAX Baxter International Inc. Buy 4.6% 1.16%
OMCL Omnicell, Inc. Buy 4.59% 0.97%
ADMA ADMA Biologics, Inc. Buy 4.58% 0.65%
TVTX Travere Therapeutics, Inc. Buy 4.6% 1.16%
CERS Cerus Corporation Buy 4.47% -1.65%
PCRX Pacira BioSciences, Inc. Buy 4.63% 1.76%
ABUS Arbutus Biopharma Corporation Buy 4.99% 0%
The percentage of cash held in the portfolio is: 11.98%
New Assets Added
  • ABUS
Assets Removed
Asset Action Perf %
RCM Sell All 27.04%
MTD Sell All 13.23%
Assets Rebalanced
None
2024-03-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 5.42% 24.71%
MTD Mettler-Toledo International Inc. Buy 4.78% 9.97%
PTGX Protagonist Therapeutics, Inc. Buy 4.99% 9.8%
THC Tenet Healthcare Corporation Buy 5.1% 3.23%
MRSN Mersana Therapeutics, Inc. Buy 4.77% -3.37%
ENTA Enanta Pharmaceuticals, Inc. Buy 5.04% 2.02%
RDNT RadNet, Inc. Buy 5.4% 9.36%
NTRA Natera, Inc. Buy 4.99% 0.91%
QTRX Quanterix Corporation Buy 4.91% 0.75%
BHVN Biohaven Ltd. Buy 5.03% 3.09%
RGNX REGENXBIO Inc. Buy 5.48% 12.36%
ACRS Aclaris Therapeutics, Inc. Buy 5.62% 15.2%
APLS Apellis Pharmaceuticals, Inc. Buy 4.6% -5.71%
BAX Baxter International Inc. Buy 4.55% 0%
OMCL Omnicell, Inc. Buy 4.55% 0%
ADMA ADMA Biologics, Inc. Buy 4.55% 0%
TVTX Travere Therapeutics, Inc. Buy 4.55% 0%
CERS Cerus Corporation Buy 4.55% 0%
PCRX Pacira BioSciences, Inc. Buy 4.55% 0%
The percentage of cash held in the portfolio is: 6.55%
New Assets Added
  • BAX
  • OMCL
  • ADMA
  • TVTX
  • CERS
  • PCRX
Assets Removed
Asset Action Perf %
NUTX Sell All -12.3%
BRKR Sell All 13.09%
Assets Rebalanced
None
2024-03-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 3.93% -11.48%
BRKR Bruker Corporation Buy 5% 12.64%
RCM R1 RCM Inc. Buy 5.49% 25.07%
MTD Mettler-Toledo International Inc. Buy 4.73% 7.9%
PTGX Protagonist Therapeutics, Inc. Buy 4.99% 8.71%
THC Tenet Healthcare Corporation Buy 5.06% 1.35%
MRSN Mersana Therapeutics, Inc. Buy 4.85% -2.86%
ENTA Enanta Pharmaceuticals, Inc. Buy 4.9% -1.89%
RDNT RadNet, Inc. Buy 5.34% 6.94%
NTRA Natera, Inc. Buy 4.89% -2%
QTRX Quanterix Corporation Buy 4.95% 0.5%
BHVN Biohaven Ltd. Buy 5.12% 4.01%
RGNX REGENXBIO Inc. Buy 5.68% 15.22%
ACRS Aclaris Therapeutics, Inc. Buy 5.01% 1.6%
APLS Apellis Pharmaceuticals, Inc. Buy 4.76% -3.34%
The percentage of cash held in the portfolio is: 25.3%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMEH Sell All 3.65%
Assets Rebalanced
None
2024-03-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 4.16% -6.56%
BRKR Bruker Corporation Buy 5.01% 12.49%
RCM R1 RCM Inc. Buy 5.51% 25.25%
MTD Mettler-Toledo International Inc. Buy 4.75% 7.87%
AMEH Apollo Medical Holdings, Inc. Buy 3.68% 5.35%
PTGX Protagonist Therapeutics, Inc. Buy 5.12% 11.13%
THC Tenet Healthcare Corporation Buy 4.98% -0.63%
MRSN Mersana Therapeutics, Inc. Buy 4.85% -3.2%
ENTA Enanta Pharmaceuticals, Inc. Buy 5.11% 1.95%
RDNT RadNet, Inc. Buy 5.29% 5.61%
NTRA Natera, Inc. Buy 5.05% 0.89%
QTRX Quanterix Corporation Buy 4.94% 0%
BHVN Biohaven Ltd. Buy 4.94% 0%
RGNX REGENXBIO Inc. Buy 4.94% 0%
ACRS Aclaris Therapeutics, Inc. Buy 4.94% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 4.94% 0%
The percentage of cash held in the portfolio is: 21.77%
New Assets Added
  • QTRX
  • BHVN
  • RGNX
  • ACRS
  • APLS
Assets Removed
Asset Action Perf %
OMI Sell All 15.7%
RVNC Sell All -14.99%
Assets Rebalanced
None
2024-03-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMI Owens & Minor, Inc. Buy 5.05% 14.13%
NUTX Nutex Health Inc. Buy 4.12% -7.38%
BRKR Bruker Corporation Buy 4.91% 10.34%
RCM R1 RCM Inc. Buy 5.51% 25.34%
MTD Mettler-Toledo International Inc. Buy 4.67% 6.31%
AMEH Apollo Medical Holdings, Inc. Buy 3.64% 4.48%
PTGX Protagonist Therapeutics, Inc. Buy 5.19% 12.89%
RVNC Revance Therapeutics, Inc. Buy 4.93% -2.24%
THC Tenet Healthcare Corporation Buy 5% 0%
MRSN Mersana Therapeutics, Inc. Buy 5% 0%
ENTA Enanta Pharmaceuticals, Inc. Buy 5% 0%
RDNT RadNet, Inc. Buy 5% 0%
NTRA Natera, Inc. Buy 5% 0%
The percentage of cash held in the portfolio is: 36.99%
New Assets Added
  • THC
  • MRSN
  • ENTA
  • RDNT
  • NTRA
Assets Removed
Asset Action Perf %
FATE Sell All 23.05%
CHRS Sell All -8.02%
Assets Rebalanced
None
2024-03-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 5.06% 12.72%
CHRS Coherus BioSciences, Inc. Buy 3.9% -12.98%
OMI Owens & Minor, Inc. Buy 5.04% 12.69%
NUTX Nutex Health Inc. Buy 4.16% -7.38%
BRKR Bruker Corporation Buy 4.85% 8.11%
RCM R1 RCM Inc. Buy 5.58% 25.78%
MTD Mettler-Toledo International Inc. Buy 4.64% 4.57%
AMEH Apollo Medical Holdings, Inc. Buy 3.8% 8.01%
PTGX Protagonist Therapeutics, Inc. Buy 4.95% 6.67%
RVNC Revance Therapeutics, Inc. Buy 5.09% 0%
The percentage of cash held in the portfolio is: 52.93%
New Assets Added
  • RVNC
Assets Removed
Asset Action Perf %
CARA Sell All 32.4%
NVAX Sell All 14.88%
VRDN Sell All -7.24%
CERS Sell All -5.22%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings